Kullmann, DM;
(2025)
Recent progress and challenges in gene therapy for pharmacoresistant focal epilepsy.
Revue Neurologique
10.1016/j.neurol.2025.02.008.
(In press).
|
Text
Kullmann_RevNeurol_DK02.pdf Access restricted to UCL open access staff until 30 March 2026. Download (282kB) |
Abstract
Pharmacoresistant focal epilepsy represents a major unmet need. Recent years have seen several gene therapy strategies validated mainly in rodent models of temporal lobe epilepsy, and some of these have been de-risked for clinical trials. This review considers some of the challenges in progressing from experimental models to the clinic. Among these are identifying promising promoter-transgene combinations, establishing safe and efficacious doses, achieving optimal delivery, and extrapolating across different aetiologies.
Archive Staff Only
![]() |
View Item |

